Harmony Biosciences LLC
Plymouth Meeting, PA Harmony Biosciences, LLC
- UEI
- TD8KAL6BNW67
- CAGE
- 88TU1
- Primary NAICS
- 325412 Pharmaceutical Preparation Manufacturing
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
- SAM.gov registration date
- Physical address
- 630 W Germantown Pike, Plymouth Meeting, PA 19462, USA
- Website
- harmonybiosciences.com
- Founded
- 2017
- Employees
- 51-250
- Estimated annual revenue
- $10M-$50M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Bulk - wakix 17.8MG tab | Veterans Integrated Service Network 20 | $635,245 | |
| Wakix 17.8 MG | Veterans Integrated Service Network 5 | $10,418 | |
| Wakix 17.8 MG | Veterans Integrated Service Network 5 | $10,418 | |
| Wakix 17.8 MG | Veterans Integrated Service Network 5 | $10,418 | |
| Wakix 17.8 MG | Veterans Integrated Service Network 5 | $10,418 |
About Harmony Biosciences LLC
Harmony Biosciences LLC is a for-profit pharmaceutical company headquartered in Plymouth Meeting, Pennsylvania, that specializes in developing and manufacturing medications for rare neurological diseases and sleep disorders. The company operates as a limited liability corporation and serves as a prime contractor to the federal government, with a registered SAM.gov entity beginning in February 2019. Through its federal contracting activities, Harmony Biosciences primarily supplies specialized pharmaceutical products to support veteran healthcare needs across the U.S. Department of Veterans Affairs healthcare system.
Harmony Biosciences LLC has provided extensive federal contracting services exclusively to the Department of Veterans Affairs through delivery orders placed against the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB). The company's primary product supplied through these contracts is WAKIX (pitolisant) 17.8 mg tablets, a prescription medication used to treat excessive daytime sleepiness and cataplexy in adult patients with narcolepsy. The delivery orders have ranged significantly in value, from approximately $5,000 to over $700,000 per order, with multiple orders issued to various Veterans Integrated Service Networks (VISN) including VISN 5, VISN 20, and VISN 21, serving VA medical centers and healthcare facilities nationwide. All contract awards have been issued without set-aside designations, indicating they were competitively awarded among qualified vendors. The contracts are firm fixed-price delivery orders, with performance primarily taking place at the company's location in Plymouth Meeting, Pennsylvania, and various VA medical centers. No subcontractors or sub-tier partners have been identified in the contract documentation, and all awards have been directly to Harmony Biosciences as the prime contractor.
Harmony Biosciences LLC currently holds a single-award Blanket Purchase Agreement (BPA) valued at $25,000,000 with the U.S. Department of Veterans Affairs National Acquisition Center, awarded on June 18, 2025, with an ultimate completion date of June 17, 2026. This BPA operates under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) and enables the Veterans Health Administration to issue flexible delivery orders for WAKIX across multiple Veterans Integrated Service Networks throughout the fiscal year without requiring separate competitive solicitations for each requirement. The BPA was awarded without set-aside designations and provides substantial purchasing flexibility for VA medical centers to obtain WAKIX 17.8 mg tablets consistently throughout the performance period. This $25,000,000 BPA represents a significant expansion of the company's prior contracting relationship with the VA, which previously relied on individual delivery orders and a smaller $259,000 multiple-award indefinite-delivery indefinite-quantity (IDIQ) contract. The BPA structure streamlines procurement efficiency and ensures consistent supply availability of this specialized pharmaceutical product for veteran patients requiring treatment for narcolepsy-related symptoms across the entire VA healthcare system.
Contract vehicles
Quick answers
What is Harmony Biosciences LLC's UEI?
Harmony Biosciences LLC's Unique Entity ID (UEI) in SAM.gov is TD8KAL6BNW67.
What is Harmony Biosciences LLC's CAGE code?
Harmony Biosciences LLC's CAGE code is 88TU1.
What is Harmony Biosciences LLC's primary NAICS code?
Harmony Biosciences LLC's primary NAICS code is 325412 (Pharmaceutical Preparation Manufacturing).
Where is Harmony Biosciences LLC located?
Harmony Biosciences LLC's physical address in SAM.gov is 630 W Germantown Pike, Plymouth Meeting, PA 19462, USA.
Is Harmony Biosciences LLC registered in SAM.gov?
Yes. Harmony Biosciences LLC's SAM.gov registration is active through January 14, 2027.
Which contract vehicles does Harmony Biosciences LLC hold?
Harmony Biosciences LLC holds a place on 1 federal contract vehicle: FSS-61-IB.
What is Harmony Biosciences LLC's most recent federal award?
Harmony Biosciences LLC's most recent federal contract award is Bulk - wakix 17.8MG tab (36C26026F0062), from Veterans Integrated Service Network 20, on December 1, 2025.
On GovTribe
See Harmony Biosciences LLC's full federal record
- Federal contract awards
- IDV awards
- Contract vehicles
- Funding analysis by agency, NAICS and set-aside
- Similar vendors